Explores non-opioid analgesic efficacy in postoperative pain management, suggesting viable alternatives to opioids.
Suzetrigine has generated understandable enthusiasm as a first-in-class, non-opioid analgesic targeting peripheral Nav1.8 sodium channels. For perioperative clinicians seeking alternatives to opioid-centered pain management, this mechanism is attractive. Yet two distinct challenges must be
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: